Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles
Tanyalak Parimon, Changfu Yao, David M. Habiel, Lingyin Ge, Stephanie A. Bora, Rena Brauer, Christopher M. Evans, Ting Xie, Felix Alonso-Valenteen, Lali K. Medina-Kauwe, Dianhua Jiang, Paul W. Noble, Cory M. Hogaboam, Nan Deng, Olivier Burgy, Travis J. Antes, Melanie Königshoff, Barry R. Stripp, Sina A. Gharib, Peter Chen
Tanyalak Parimon, Changfu Yao, David M. Habiel, Lingyin Ge, Stephanie A. Bora, Rena Brauer, Christopher M. Evans, Ting Xie, Felix Alonso-Valenteen, Lali K. Medina-Kauwe, Dianhua Jiang, Paul W. Noble, Cory M. Hogaboam, Nan Deng, Olivier Burgy, Travis J. Antes, Melanie Königshoff, Barry R. Stripp, Sina A. Gharib, Peter Chen
View: Text | PDF
Research Article Pulmonology

Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles

  • Text
  • PDF
Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal lung disease. A maladaptive epithelium due to chronic injury is a prominent feature and contributor to pathogenic cellular communication in IPF. Recent data highlight the concept of a “reprogrammed” lung epithelium as critical in the development of lung fibrosis. Extracellular vesicles (EVs) are potent mediators of cellular crosstalk, and recent evidence supports their role in lung pathologies, such as IPF. Here, we demonstrate that syndecan-1 is overexpressed by the epithelium in the lungs of patients with IPF and in murine models after bleomycin injury. Moreover, we find that syndecan-1 is a profibrotic signal that alters alveolar type II cell phenotypes by augmenting TGF-β and Wnt signaling among other profibrotic pathways. Importantly, we demonstrate that syndecan-1 controls the packaging of several antifibrotic microRNAs into EVs that have broad effects over several fibrogenic signaling networks as a mechanism of regulating epithelial plasticity and pulmonary fibrosis. Collectively, our work reveals new insight into how EVs orchestrate cellular signals that promote lung fibrosis and demonstrate the importance of syndecan-1 in coordinating these programs.

Authors

Tanyalak Parimon, Changfu Yao, David M. Habiel, Lingyin Ge, Stephanie A. Bora, Rena Brauer, Christopher M. Evans, Ting Xie, Felix Alonso-Valenteen, Lali K. Medina-Kauwe, Dianhua Jiang, Paul W. Noble, Cory M. Hogaboam, Nan Deng, Olivier Burgy, Travis J. Antes, Melanie Königshoff, Barry R. Stripp, Sina A. Gharib, Peter Chen

×

Figure 3

Syndecan-1 regulates alveolar epithelial reprogramming by facilitating TGF-β and Wnt signaling.

Options: View larger image (or click on image) Download as PowerPoint
Syndecan-1 regulates alveolar epithelial reprogramming by facilitating T...
Uninjured or bleomycin-injured (0.75 unit/kg; 21 days) WT and Sdc1–/– mice (n = 3 per condition) were sacrificed and processed for scRNA-Seq of cells isolated from dissociated lungs. (A) t-SNE plots of ATII cells were generated by the Loupe Cell Browser (10× Genomics). (B) Hierarchical cluster analysis of differentially expressed genes (genotype × condition) in ATII cells between control and bleomycin-injured WT and Sdc1–/– mice. (C) Using genes significantly upregulated (FDR < 0.01) in ATII cells of bleomycin-injured WT lungs relative to Sdc1–/– lungs, a KEGG pathway analysis was performed to determine the significantly enriched functional pathways represented by the gene set. Bars indicate the number of genes in the pathway, and color indicates FDR level of the KEGG analysis. (D) Heatmap of the expression (transcript counts) of epithelial-derived profibrotic mediators that were significantly different in scRNA-Seq analysis of ATII cells from WT compared with Sdc1–/– mice. (E) Cluster network analysis using Ingenuity Pathway Analysis (QIAGEN Inc.; www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/) of differentially expressed genes between ATII cells in WT and Sdc1–/– mice identified TGF-β signaling as a highly significant upstream regulator (P < 10–60). (F) Wnt signaling interaction network using β-catenin (Ctnnb1) as a seed to visualize the connectivity of differentially expressed genes in ATII cells between WT and Sdc1–/– mice. The majority of genes interacting with Wnt signaling were upregulated in WT conditions. Please refer to Supplemental Figure 5 for an annotated version with the gene symbols.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts